ChiHsin King - Taigen Biopharmaceutica VP Research
| 4157 Stock | TWD 12.25 0.30 2.39% |
Insider
ChiHsin King is VP Research of Taigen Biopharmaceuticals Holdings
| Age | 75 |
| Phone | 886 2 8177 7020 |
| Web | https://www.taigenbiotech.com.tw |
Taigen Biopharmaceutica Management Efficiency
The company has return on total asset (ROA) of (0.1483) % which means that it has lost $0.1483 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2147) %, meaning that it generated substantial loss on money invested by shareholders. Taigen Biopharmaceutica's management efficiency ratios could be used to measure how well Taigen Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities. Taigen Biopharmaceuticals Holdings (4157) is traded on Taiwan OTC Exchange in Taiwan and employs 23 people.Management Performance
| Return On Equity | -0.21 | |||
| Return On Asset | -0.15 |
Taigen Biopharmaceutica Leadership Team
Elected by the shareholders, the Taigen Biopharmaceutica's board of directors comprises two types of representatives: Taigen Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taigen. The board's role is to monitor Taigen Biopharmaceutica's management team and ensure that shareholders' interests are well served. Taigen Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taigen Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChiHsin King, VP Research | ||
| MingChu Hsu, Founder Director | ||
| KuoLung Huang, CEO, Chairman | ||
| Richard Lu, VP Fin |
Taigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Taigen Biopharmaceutica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.21 | |||
| Return On Asset | -0.15 | |||
| Operating Margin | (9.40) % | |||
| Current Valuation | 11.41 B | |||
| Shares Outstanding | 716.84 M | |||
| Shares Owned By Insiders | 35.93 % | |||
| Shares Owned By Institutions | 24.94 % | |||
| Price To Book | 11.51 X | |||
| Price To Sales | 369.99 X | |||
| Revenue | 1.29 B |
Pair Trading with Taigen Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Taigen Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taigen Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with Taigen Stock
| 0.68 | 1516 | Falcon Power Split | PairCorr |
| 0.73 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.73 | 1435 | Chung Fu Tex | PairCorr |
| 0.77 | 1423 | Reward Wool Industry | PairCorr |
Moving against Taigen Stock
The ability to find closely correlated positions to Taigen Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Taigen Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Taigen Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Taigen Biopharmaceuticals Holdings to buy it.
The correlation of Taigen Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Taigen Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Taigen Biopharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Taigen Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.